Virtus Logo
Contact

PUBLICATIONS

Publications highlighting the various clinical and pre-clinical work performed by Virtus experts to date.

Jackson DJ, Makrinioti H, Rana BM, Shamji BW, Trujillo-Torralbo MB, Footitt J, Del-Rosario J, Telcian AG, Nikonova A, Zhu J, Aniscenko J, Gogsadze L, Bakhsoliani E, Traub S, Dhariwal J, Porter J, Hunt D, Hunt T, Hunt T, Stanciu LA, Khaitov M, Bartlett NW, Edwards MR, Kon OM, Mallia P, Papadopoulos NG, Akdis CA, Westwick J, Edwards MJ, Walton RP, Johnston SL.

Am J Respir Crit Care Med. 2014 Dec 15;190(12):1373-82

Contoli M, Message SD, Laza-Stanca V, Edwards MR, Wark PA, Bartlett NW, Kebadze T, Mallia P, Stanciu LA, Parker HL, Slater L, Lewis-Antes A, Kon OM, Holgate ST, Davies DE, Kotenko SV, Papi A, Johnston SL.

Nat Med. 2006 Sep;12(9):1023-6. Epub 2006 Aug 13.

Message SD, Laza-Stanca V, Mallia P, Parker HL, Zhu J, Kebadze T, Contoli M, Sanderson G, Kon OM, Papi A, Jeffery PK, Stanciu LA, Johnston SL

Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13562-7.

Dhariwal J, Cameron A, Trujillo-Torralbo MB, Del Rosario A, Bakhsoliani E, Paulsen M, Jackson DJ, Edwards MR, Rana BMJ, Cousins DJ, Hansel TT, Johnston SL, Walton RP

Am J Respir Crit Care Med. 2017 Jun 15;195(12):1586-1596

Footitt J, Mallia P, Durham AL, Ho WE, Trujillo-Torralbo MB, Telcian AG, Del Rosario A, Chang C, Peh HY, Kebadze T, Aniscenko J, Stanciu L, Essilfie-Quaye S, Ito K, Barnes PJ, Elkin SL, Kon OM, Wong WS, Adcock IM, Johnston SL.

Chest. 2016 Jan;149(1):62-73.

Mallia P, Footitt J, Sotero R, Jepson A, Contoli M, Trujillo-Torralbo MB, Kebadze T, Aniscenko J, Oleszkiewicz G, Gray K, Message SD, Ito K, Barnes PJ, Adcock IM, Papi A, Stanciu LA, Elkin SL, Kon OM, Johnson M, Johnston SL

Am J Respir Crit Care Med. 2012 Dec 1; 186(11):1117-24.

Mallia P, Message SD, Gielen V, Contoli M, Gray K, Kebadze T, Aniscenko J, Laza-Stanca V, Edwards MR, Slater L, Papi A, Stanciu LA, Kon OM, Johnson M, Johnston SL.

Am J Respir Crit Care Med. 2011 Mar 15;183(6):734-42.z

Singanayagam A, Glanville N, Girkin JL, Ching YM, Marcellini A, Porter JD, Toussaint M, Walton RP, Finney LJ, Aniscenko J, Zhu J, Trujillo-Torralbo MB, Calderazzo MA, Grainge C, Loo SL, Veerati PC, Pathinayake PS, Nichol KS, Reid AT, James PL, Solari R, Wark PAB, Knight DA, Moffatt MF, Cookson WO, Edwards MR, Mallia P, Bartlett NW, Johnston SL.

Nat Commun. 2018 Jun 8;9(1):2229

Toussaint M, Jackson DJ, Swieboda D, Guedán A, Tsourouktsoglou TD, Ching YM, Radermecker C, Makrinioti H, Aniscenko J, Bartlett NW, Edwards MR, Solari R, Farnir F, Papayannopoulos V, Bureau F, Marichal T, Johnston SL.

Nat Med. 2017 Jun;23(6):681-691

Zhu J, Message SD, Mallia P, Kebadze T, Contoli M, Ward CK, Barnathan ES, Mascelli MA, Kon OM, Papi A, Stanciu LA, Edwards MR, Jeffery PK, Johnston SL.

J Allergy Clin Immunol. 2019 Jan;143(1):114-125.e4

Get in touch

Want to find out more how we can help you develop the next block-buster medicine in asthma or COPD? Get in touch.

Latest from Virtus

#ERSCongress - Precision meets immunology. Nice talk by Prof. Pavord showing that dupilumab reduces AE most impressively in high FeNO, high eos T2 asthmatics.

Could this be restoration of impaired anti-viral immunity?
See

#VirTus

#ERSCongress – Hot topics: microbiome, infection and host defence. Prof Smits discusses parasites, microbiota and their influence on the immune system.

Is H. polygyrus the next source of T2 cytokine blockers? Watch this space.

#ERS2019 #Asthma #VirTus #ERSTalks

#ERSCongress – In beyond T2 mechanisms in asthma, phages as magic bullets Prof J Simpson: surely the lung immune response is not aimed solely at bacteria but the phages they contain? Phages as a source of inflammation?

#ERS2019 #Asthma #Inflammation #VirTus

#ERSCongress – In beyond T2 mechanisms in asthma, phages as magic bullets by Prof. J Simpson.
Are we heading towards mapping out the respiratory phagome?
#ERS2019 #Asthma #VirTus

#ERSCongress It takes 2 to tango: Prof Nair interesting talk on T cell biology and eos; TH2 cells remain an elusive target. Also, a great overview of potential importance of DR3/TL1a signalling in ILC2 and eosinophilia crosstalk. Surely the next big target in T2 asthma!
#ERSTalks

#ERSCongress – It takes 2 to tango: Prof HJ Hoffmann gave a great talk on IgE mast cell interactions and possible implications for asthma severity.

#ERS2019 #Asthma #VirTus #ERSTalks

#ERSCongress – It takes 2 to tango: Prof P Bradding discussion on the effects of SABAs on mast cell function. Shows how little we know about the immunomodulatory effects of beta2agonists, both harmful and beneficial.

#ERS2019 #Asthma #COPD #VirTus

#ERSCongress – New recommendations and priorities for asthma management: Prof @Sebastian Johnston gives keynote speech on the risk of asthma deaths and beta-2-agonist overuse.

#ERS2019 #Asthma #VirTus #ERSTalks

More Tweets

Keep Updated With Our Progress

Keep up with the latest results, news and other headlines from Virtus Respiratory Research.

The email address is incorrect
Please agree to our Privacy and Policy
Something went wrong